UTHSCT gynecologist to discuss latest findings on benefits, risks of hormone replacement therapy at free Nov. 12 seminar

Thursday, November 5, 2009

In 2002, a national clinical trial of the health effects of estrogen and progestin in menopausal women was halted after it indicated the hormone replacement therapy raised participants’ risk of breast cancer, heart attacks, and strokes.

However, in the past few years some have questioned the results of this clinical trial. If you’re a woman going through menopause, it’s hard to sort through the conflicting viewpoints.

“Hormone Replacement Therapy: Revisiting the Decision Seven Years Later,” a free seminar to be held from 10 a.m. to 11:30 a.m. Thursday, Nov. 12, at The University of Texas Health Science Center at Tyler will help you separate the hype from the facts surrounding HRT.

UTHSCT gynecologist Ralph J. Turner, MD, will outline the pros and cons of hormone replacement therapy.

Dr. Turner, a board-certified gynecologist with more than 20 years experience in women’s health, will discuss how appropriate use of HRT can help women feel stronger and more vital as they go through menopause.

The seminar will be held in the Biomedical Research Center Auditorium on the UTHSCT campus, located at the intersection of U.S. 271 and Texas 155.

It is free, but seating is limited and reservations are required. Free refreshments and free valet parking also will be available.

For information or to register, call (903) 877-7147.

For 60 years, The University of Texas Health Science Center at Tyler has provided excellent patient care and cutting-edge treatments, specializing in pulmonary disease, cancer, heart disease, primary care, and the disciplines that support them. With an operating budget of more than $125 million and biomedical research funding that exceeds $10 million annually, UTHSCT has a major economic impact on East Texas. Its two medical residency programs – in family medicine and occupational medicine – provide doctors for many communities in East Texas and beyond.

NOTICE: Protected health information is subject to electronic disclosure.